|
1
|
Welgus HG, Campbell EJ, Cury JD, Eisen AZ,
Senior RM, Wilhelm SM and Goldberg GI: Neutral metalloproteinases
produced by human mononuclear phagocytes. Enzyme profile,
regulation, and expression during cellular development. J Clin
Invest. 86:1496–1502. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chiao YA, Ramirez TA, Zamilpa R, Okoronkwo
SM, Dai Q, Zhang J, Jin YF and Lindsey ML: Matrix
metalloproteinase-9 deletion attenuates myocardial fibrosis and
diastolic dysfunction in ageing mice. Cardiovasc Res. 96:444–455.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arroyo-Espliguero R, Avanzas P,
Cosín-Sales J, Aldama G, Pizzi C and Kaski JC: C-reactive protein
elevation and disease activity in patients with coronary artery
disease. Eur Heart J. 25:401–408. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fujimoto N, Mouri N, Iwata K, Ohuchi E,
Okada Y and Hayakawa T: A one-step sandwich enzyme immunoassay for
human matrix metalloproteinase 2 (72-kDa gelatinase/type IV
collagenase) using monoclonal antibodies. Clin Chim Acta.
221:91–103. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fujimoto N, Hosokawa N, Iwata K, Okada Y
and Hayakawa T: A one-step sandwich enzyme immunoassay for human
matrix metalloproteinase 9 using monoclonal antibodies. Ann N Y
Acad Sci. 732:359–361. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sundström J and Vasan RS: Circulating
biomarkers of extracellular matrix remodeling and risk of
atherosclerotic events. Curr Opin Lipidol. 17:45–53. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK,
Park JY, Lee KU, Kim JG and Lee IK: Alpha-lipoic acid inhibits
matrix metalloproteinase-9 expression by inhibiting NF-kappaB
transcriptional activity. Exp Mol Med. 39:106–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gross J and Lapiere CM: Collagenolytic
activity in amphibian tissues: A tissue culture assay. Proc Natl
Acad Sci USA. 48:pp. 1014–1022. 1962, View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galis ZS, Sukhova GK, Lark MW and Libby P:
Increased expression of matrix metalloproteinases and matrix
degrading activity in vulnerable regions of human atherosclerotic
plaques. J Clin Invest. 94:2493–2503. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Major TC, Liang L, Lu X, Rosebury W and
Bocan TM: Extracellular matrix metalloproteinase inducer (EMMPRIN)
is induced upon monocyte differentiation and is expressed in human
atheroma. Arterioscler Thromb Vasc Biol. 22:1200–1207. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chandrasekar B, Mummidi S, Mahimainathan
L, Patel DN, Bailey SR, Imam SZ, Greene WC and Valente AJ:
Interleukin-18-induced human coronary artery smooth muscle cell
migration is dependent on NF-kappaB- and AP-1-mediated matrix
metalloproteinase-9 expression and is inhibited by atorvastatin. J
Biol Chem. 281:15099–15109. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnson JL, George SJ, Newby AC and
Jackson CL: Divergent effects of matrix metalloproteinases 3, 7, 9
and 12 on atherosclerotic plaque stability in mouse brachiocephalic
arteries. Proc Natl Acad Sci USA. 102:pp. 15575–15580. 2005,
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reunanen N, Westermarck J, Häkkinen L,
Holmström TH, Elo I, Eriksson JE and Kähäri VM: Enhancement of
fibroblast collagenase (matrix metalloproteinase-1) gene expression
by ceramide is mediated by extracellular signal-regulated and
stress-activated protein kinase pathways. J Biol Chem.
273:5137–5145. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McCawley LJ, Li S, Wattenberg EV and
Hudson LG: Sustained activation of the mitogen-activated protein
kinase pathway. A mechanism underlying receptor tyrosine kinase
specificity for matrix metalloproteinase-9 induction and cell
migration. J Biol Chem. 274:4347–4353. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lai CS, Lee JH, Ho CT, Liu CB, Wang JM,
Wang YJ and Pan MH: Rosmanol potently inhibits
lipopolysaccharide-induced iNOS and COX-2 expression through
downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways.
J Agric Food Chem. 57:10990–10998. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baud V and Karin M: Signal transduction by
tumor necrosis factor and its relatives. Trends Cell Biol.
11:372–377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wajant H, Pfizenmaier K and Scheurich P:
Tumor necrosis factor signaling. Cell Death Differ. 10:45–65. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Robinson MJ and Cobb MH: Mitogen-activated
protein kinase pathways. Curr Opin Cell Biol. 9:180–186. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Holvoet S, Vincent C, Schmitt D and Serres
M: The inhibition of MAPK pathway is correlated with
down-regulation of MMP-9 secretion induced by TNF-alpha in human
keratinocytes. Exp Cell Res. 290:108–119. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhee JW, Lee KW, Kim D, Lee Y, Jeon OH,
Kwon HJ and Kim DS: NF-kappaB-dependent regulation of matrix
metalloproteinase-9 gene expression by lipopolysaccharidein a
macrophage cell line RAW 264.7. J Biochem Mol Biol. 40:88–94.
2007.PubMed/NCBI
|
|
24
|
Westermarck J and Kähäri VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999.PubMed/NCBI
|
|
25
|
Meisser A, Chardonnens D, Campana A and
Bischof P: Effects of tumour necrosis factor-alpha, interleukin-1
alpha, macrophage colony stimulating factor and transforming growth
factor beta on trophoblastic matrix metalloproteinases. Mol Hum
Reprod. 5:252–260. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Antithrombotic Trialists' Collaboration:
Collaborative meta-analysis of randomised trials of antiplatelet
therapy for prevention of death, myocardial infarction, and stroke
in high risk patients. BMJ. 324:71–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mazzone A, Venneri L and Berti S: Aortic
valve stenosis and coronary artery disease: Pathophysiological and
clinical links. J Cardiovasc Med (Hagerstown). 8:983–989. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hua Y, Xue J, Sun F, Zhu L and Xie M:
Aspirin inhibits MMP-2 and MMP-9 expressions and activities through
upregulation of PPARalpha/gamma and TIMP gene expressions in
ox-LDL-stimulated macrophages derived from human monocytes.
Pharmacology. 83:18–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tan JX, Shi W, Liao AJ, Peng AB and Zeng
B: Effect of Pyrrolidine Dithiocarbamate (PDTC) on NF-κB activity
of pancreatic acinar cells and blood inflammatory cytokines in
murine. Chin J Clin Gastroenterol. 19:147–149. 2007.
|
|
30
|
Cho A, Graves J and Reidy MA:
Mitogen-activated protein kinases mediate matrix
metalloproteinase-9 expression in vascular smooth muscle cells.
Arteriosclerosis, Thrombosis and Vascular Biology. 20:2527–2532.
2000. View Article : Google Scholar
|
|
31
|
Kim HH, Lee Y, Eun HC and Chung JH:
Eicosapentaenoic acid inhibits TNF-alpha-induced matrix
metalloproteinase-9 expression in human keratinocytes, HaCaT cells.
Biochem Biophys Res Commun. 368:343–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moon SK, Cha BY and Kim CH: ERK1/2
mediates TNF-alpha-induced matrix metalloproteinase-9 expression in
human vascular smooth muscle cells via the regulation of NF-kappaB
and AP-1: Involvement of the ras dependent pathway. J Cell Physiol.
198:417–427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho A, Graves J and Reidy MA:
Mitogen-activated protein kinases mediate matrix
metalloproteinase-9 expression in vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol. 20:2527–2532. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim KC and Lee CH: MAP kinase activation
is required for the MMP-9 induction by TNF-stimulation. Arch Pharm
Res. 28:1257–1262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ley K, Miller YI and Hedrick CC: Monocyte
and macrophage dynamics during atherogenesis. Arterioscler Thromb
Vasc Biol. 31:1506–1516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peters KD, Kochanek KD and Murphy SL:
Deaths: Final data for 1996. Natl Vital Stat Rep. 47:1–100.
1998.PubMed/NCBI
|
|
37
|
Cyrus T, Sung S, Zhao L, Funk CD, Tang S
and Praticò D: Effect of low-dose aspirin on vascular inflammation,
plaque stability, and atherogenesis in low-density lipoprotein
receptor-deficient mice. Circulation. 106:1282–1287. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yiqin Y, Meilin X, Jie X and Keping Z:
Aspirin inhibits MMP-2 and MMP-9 expression and activity through
PPARalpha/gamma and TIMP-1-mediated mechanisms in cultured mouse
celiac macrophages. Inflammation. 32:233–241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Blankenberg S, Rupprecht HJ, Poirier O,
Bickel C, Smieja M, Hafner G, Meyer J, Cambien F and Tiret L:
AtheroGene Investigators: Plasma concentrations and genetic
variation of matrix metalloproteinase 9 and prognosis of patients
with cardiovascular disease. Circulation. 107:1579–1585. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wågsäter D, Zhu C, Björkegren J, Skogsberg
J and Eriksson P: MMP-2 and MMP-9 are prominent matrix
metalloproteinases during atherosclerosis development in the
Ldlr(−/-)Apob(100/100) mouse. Int J Mol Med. 28:247–253.
2011.PubMed/NCBI
|
|
44
|
Birkedal-Hansen H, Moore WG, Bodden MK,
Windsor LJ, Birkedal-Hansen B, DeCarlo A and Engler JA: Matrix
metalloproteinases: A review. Crit Rev Oral Biol Med. 4:197–250.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fabunmi RP, Baker AH, Murray EJ, Booth RF
and Newby AC: Divergent regulation by growth factors and cytokines
of 95 kDa and 72 kDa gelatinases and tissue inhibitors or
metalloproteinases-1, −2 and −3 in rabbit aortic smooth muscle
cells. Biochem J. 315:335–342. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Borden P and Heller RA: Transcriptional
control of matrix metalloproteinases and the tissue inhibitors of
matrix metalloproteinases. Crit Rev Eukaryot Gene Expr. 7:159–178.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bond M, Fabunmi RP, Baker AH and Newby AC:
Synergistic upregulation of metalloproteinase-9 by growth factors
and inflammatory cytokines: An absolute requirement for
transcription factor NF-kappa B. FEBS Lett. 435:29–34. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lu L, Liu H, Peng J, Gan L, Shen L, Zhang
Q, Li L, Zhang L, Su C and Jiang Y: Regulations of the key
mediators in inflammation and atherosclerosis by aspirin in human
macrophages. Lipids Health Dis. 9:162010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Suh SJ, Cho KJ, Moon TC, Chang HW, Park YG
and Kim CH: 3,4,5-trihydroxybenzaldehyde from Geum japonicum has
dual inhibitory effect on matrix metalloproteinase 9; inhibition of
gelatinoytic activity as well as MMP-9 expression in TNF-alpha
induced HASMC. J Cell Biochem. 105:524–533. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cheng YW, Chang CY, Lin KL, Hu CM, Lin CH
and Kang JJ: Shikonin derivatives inhibited LPS-induced NOS in RAW
264.7 cells via downregulation of MAPK/NF-kappaB signaling. J
Ethnopharmacol. 120:264–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wu MJ, Wang L, Ding HY, Weng CY and Yen
JH: Glossogyne tenuifolia acts to inhibit inflammatory mediator
production in a macrophage cell line by downregulating LPS-induced
NF-kappa B. J Biomed Sci. 11:186–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Himelstein BP, Lee EJ, Sato H, Seiki M and
Muschel RJ: Tumor cell contact mediated transcriptional activation
of the fibroblast matrix metalloproteinase-9 gene: Involvement of
multiple transcription factors including Ets and an alternating
purine-pyrimidine repeat. Clin Exp Metastasis. 16:169–177. 1998.
View Article : Google Scholar : PubMed/NCBI
|
